Dissecting Prognosis Modules and Biomarkers in Glioblastoma Based on Weighted Gene Co-Expression Network Analysis

References

• Weller M , Wick W , Aldape K , et al. Glioma. Nat Rev Dis Prim . 2015.
   PubMed Web of Science ®Google Scholar
• Perry A , Wesseling P . Histologic classification of gliomas. In: Handbook of Clinical Neurology . 2016. ISBN 9780128029978.
   Google Scholar
• Karsy M , Guan J , Cohen AL , Jensen RL , Colman H . New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M. Curr Neurol Neurosci Rep . 2017;17.28229401
   PubMed Web of Science ®Google Scholar
• Eskilsson E , Røsland GV , Solecki G , et al. EGFR heterogeneity and implications for therapeutic intervention in glioblastoma. Neuro Oncol . 2018;20:743–752. doi:10.1093/neuonc/nox191.29040782
   PubMed Web of Science ®Google Scholar
• Brennan CW , Verhaak RGW , McKenna A , et al. The somatic genomic landscape of glioblastoma. Cell . 2013;155:462. doi:10.1016/j.cell.2013.09.034.24120142
   PubMed Web of Science ®Google Scholar
• Sinha S , Koul N , Dixit D , Sharma V , Sen E . IGF-1 induced HIF-1α-TLR9 cross talk regulates inflammatory responses in glioma. Cell Signal . 2011;23:1869–1875. doi:10.1016/j.cellsig.2011.06.024.21756999
   PubMed Web of Science ®Google Scholar
• Ludwig K , Kornblum HI . Molecular markers in glioma. J Neurooncol . 2017;134:505–512. doi:10.1007/s11060-017-2379-y 28233083
   PubMed Web of Science ®Google Scholar
• Eckel-Passow JE , Lachance DH , Molinaro AM , et al. Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. N Engl J Med . 2015;372:2499–2508. doi:10.1056/nejmoa1407279.26061753
   PubMed Web of Science ®Google Scholar
• Wick W , Weller M , Van Den Bent M , et al. MGMT testing - The challenges for biomarker-based glioma treatment. Nat Rev Neurol . 2014;10:372–385. doi:10.1038/nrneurol.2014.100 24912512
   PubMed Web of Science ®Google Scholar
• Wang Q , Hu B , Hu X , et al. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. Cancer Cell . 2017;32(1):42–56.e6. doi:10.1016/j.ccell.2017.06.003.28697342
   PubMed Web of Science ®Google Scholar
• Langfelder P , Horvath S . WGCNA: an R package for weighted correlation network analysis. BMC Bioinform . 2008;9. doi:10.1186/1471-2105-9-559.
   PubMed Web of Science ®Google Scholar
• Zhang Q , Zhong H , Fan Y , et al. Immune and Clinical Features of CD96 Expression in Glioma by in silico Analysis. Front Bioeng Biotechnol . 2020;8:592. doi:10.3389/fbioe.2020.00592 32695752
   PubMed Web of Science ®Google Scholar
• Zhang B , Horvath S . A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol . 2005. doi:10.2202/1544-6115.1128.
   PubMed Web of Science ®Google Scholar
• Bindea G , Mlecnik B , Hackl H , et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics . 2009;25:1091–1093. doi:10.1093/bioinformatics/btp101.19237447
   PubMed Web of Science ®Google Scholar
• Szklarczyk D , Gable AL , Lyon D , et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res . 2019;47:D607–D613. doi:10.1093/nar/gky1131.30476243
   PubMed Web of Science ®Google Scholar
• Chin CH , Chen SH , Wu HH , Ho CW , Ko MT , Lin CY . cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol . 2014;8. doi:10.1186/1752-0509-8-S4-S11.24456859
   PubMed Web of Science ®Google Scholar
• Tang Z , Kang B , Li C , Chen T , Zhang Z . GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res . 2019;47:W556–W560. doi:10.1093/nar/gkz430 31114875
   PubMed Web of Science ®Google Scholar
• Carithers LJ , Moore HM . The Genotype-Tissue Expression (GTEx) Project. Biopreserv Biobank . 2015;13:307–308. doi:10.1089/bio.2015.29031.hmm 26484569
   PubMed Web of Science ®Google Scholar
• Cao F , Zhang Q , Chen W , et al. IL-6 increases SDCBP expression, cell proliferation, and cell invasion by activating JAK2/STAT3 in human glioma cells. Am J Transl Res . 2017;9:4617–4626.29118922
   PubMed Web of Science ®Google Scholar
• Mizuno H , Kitada K , Nakai K , Sarai A . PrognoScan: a new database for meta-analysis of the prognostic value of genes. BMC Med Genomics . 2009;2. doi:10.1186/1755-8794-2-18 19133145
   PubMed Web of Science ®Google Scholar
• Xu P , Yang J , Liu J , et al. Identification of glioblastoma gene prognosis modules based on weighted gene co-expression network analysis 06 Biological Sciences 0604 Genetics. BMC Med Genomics . 2018. doi:10.1186/s12920-018-0407-1
   Web of Science ®Google Scholar
• He D , Liu ZP , Chen L . Identification of dysfunctional modules and disease genes in congenital heart disease by a network-based approach. BMC Genom . 2011. doi:10.1186/1471-2164-12-592.
   Web of Science ®Google Scholar
• Verhaak RGW , Hoadley KA , Purdom E , et al. Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell . 2010;17:98–110. doi:10.1016/j.ccr.2009.12.020.20129251
   PubMed Web of Science ®Google Scholar
• Chen B , Khodadoust MS , Liu CL , Newman AM , Alizadeh AA . Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol . 2018;Vol. 1711:pp. 243–259.
   Google Scholar
• Bouffet E , Larouche V , Campbell BB , et al. Immune checkpoint inhibition for hypermutant glioblastoma multiforme resulting from germline biallelic mismatch repair deficiency. J Clin Oncol . 2016;34:2206–2211. doi:10.1200/JCO.2016.66.6552.27001570
   PubMed Web of Science ®Google Scholar
• Li Z , Zhou J , Zhang J , Li S , Wang H , Du J . Cancer-associated fibroblasts promote PD-L1 expression in mice cancer cells via secreting CXCL5. Int J Cancer . 2019;145:1946–1957. doi:10.1002/ijc.32278.30873585
   PubMed Web of Science ®Google Scholar
• Batash R , Asna N , Schaffer P , Francis N , Schaffer M . Glioblastoma Multiforme, Diagnosis and Treatment; Recent Literature Review. Curr Med Chem . 2017;24. doi:10.2174/0929867324666170516123206.
   Web of Science ®Google Scholar
• Shergalis A , Bankhead A , Luesakul U , Muangsin N , Neamati N . Current challenges and opportunities in treating glioblastomas. Pharmacol Rev . 2018. doi:10.1124/pr.117.014944.
   PubMed Web of Science ®Google Scholar
• Lin S , Xu H , Zhang A , et al. Prognosis Analysis and Validation of m6A Signature and Tumor Immune Microenvironment in Glioma. Front Oncol . 2020. doi:10.3389/fonc.2020.541401.
   Web of Science ®Google Scholar
• Yang Q , Wang R , Wei B , et al. Candidate Biomarkers and Molecular Mechanism Investigation for Glioblastoma Multiforme Utilizing WGCNA. Biomed Res Int . 2018. doi:10.1155/2018/4246703.
   Web of Science ®Google Scholar
• Xiang Y , Zhang CQ , Huang K . Predicting glioblastoma prognosis networks using weighted gene co-expression network analysis on TCGA data. BMC Bioinform . 2012. doi:10.1186/1471-2105-13-s2-s12.
   Web of Science ®Google Scholar
• Mukherjee S . Quiescent stem cell marker genes in glioma gene networks are sufficient to distinguish between normal and glioblastoma (GBM) samples. Sci Rep . 2020. doi:10.1038/s41598-020-67753-5.
   PubMed Web of Science ®Google Scholar
• Griffith JW , Sokol CL , Luster AD . Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol . 2014;32:659–702. doi:10.1146/annurev-immunol-032713-120145 24655300
   PubMed Web of Science ®Google Scholar
• Poeta VM , Massara M , Capucetti A , Bonecchi R . Chemokines and chemokine receptors: new targets for cancer immunotherapy. Front Immunol . 2019;10.30723470
   PubMed Web of Science ®Google Scholar
• Nagarsheth N , Wicha MS , Zou W . Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol . 2017;17:559–572.28555670
   PubMed Web of Science ®Google Scholar
• Sjöberg E , Meyrath M , Milde L , et al. A novel ACKR2-Dependent role of fibroblast-derived CXCL14 in epithelial-to-mesenchymal transition and metastasis of breast cancer. Clin Cancer Res . 2019;25:3702–3717. doi:10.1158/1078-0432.CCR-18-1294.30850359
   PubMed Web of Science ®Google Scholar
• Puchert M , Obst J , Koch C , Zieger K , Engele J . CXCL11 promotes tumor progression by the biased use of the chemokine receptors CXCR3 and CXCR7. Cytokine . 2020;125:154809. doi:10.1016/j.cyto.2019.154809.31437604
   PubMed Web of Science ®Google Scholar
• Guo G , Peng Y , Xiong B , et al. Involvement of chemokine CXCL11 in the development of morphine tolerance in rats with cancer-induced bone pain. J Neurochem . 2017;141:553–564. doi:10.1111/jnc.13919.27926984
   PubMed Web of Science ®Google Scholar
• Kawamura M , Toiyama Y , Tanaka K , et al. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer. Eur J Cancer . 2012;48:2244–2251. doi:10.1016/j.ejca.2011.11.032.22197219
   PubMed Web of Science ®Google Scholar
• Zhou SL , Zhou ZJ , Hu ZQ , et al. CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling. Cancer Lett . 2015;358:124–135. doi:10.1016/j.canlet.2014.11.044.25462858
   PubMed Web of Science ®Google Scholar
• Hsu YL , Hou MF , Kuo PL , Huang YF , Tsai EM . Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/Snail signaling pathway. Oncogene . 2013;32:4436–4447. doi:10.1038/onc.2012.444.23045282
   PubMed Web of Science ®Google Scholar
• Qiu WZ , Zhang HB , Xia WX , et al. The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling. J Exp Clin Cancer Res . 2018;37. doi:10.1186/s13046-018-0722-6.
   Web of Science ®Google Scholar
• Mao Z , Zhang J , Shi Y , et al. CXCL5 promotes gastric cancer metastasis by inducing epithelial-mesenchymal transition and activating neutrophils. Oncogenesis . 2020;9. doi:10.1038/s41389-020-00249-z.
   Web of Science ®Google Scholar
• Bruyère C , Mijatovic T , Lonez C , et al. Temozolomide-induced modification of the CXC chemokine network in experimental gliomas. Int J Oncol . 2011;38:1453–1464. doi:10.3892/ijo.2011.964.21399866
   PubMed Web of Science ®Google Scholar
• Dai Z , Wu J , Chen F , et al. CXCL5 promotes the proliferation and migration of glioma cells in autocrine- and paracrine-dependent manners. Oncol Rep . 2016;36:3303–3310. doi:10.3892/or.2016.5155.27748886
   PubMed Web of Science ®Google Scholar
• Wang W , Wu KJ , Vellaisamy K , Leung CH , Ma DL . Peptide-Conjugated Long-Lived Theranostic Imaging for Targeting GRPr in Cancer and Immune Cells. Angew Chemie - Int Ed . 2020;59:17897–17902. doi:10.1002/anie.202007920.
   PubMed Web of Science ®Google Scholar
• Flores DG , Meurer L , Uberti AF , et al. Gastrin-releasing peptide receptor content in human glioma and normal brain. Brain Res Bull . 2010;82:95–98. doi:10.1016/j.brainresbull.2010.02.014.20211708
   PubMed Web of Science ®Google Scholar
• Hueso L , Ortega R , Selles F , et al. Upregulation of angiostatic chemokines IP-10/CXCL10 and I-TAC/CXCL11 in human obesity and their implication for adipose tissue angiogenesis. Int J Obes . 2018;42. doi:10.1038/s41366-018-0102-5.
   Web of Science ®Google Scholar